Look for:

Our offer for

WEST PHARMACEUTIC.SERVICES INC


ISIN:
US9553061055
WKN:
955306105

2022/08/11 22:04:43
Price
337.75 USD
Difference -0.32% (-1.09)

General attributes

ISINUS9553061055
SymbolWST
ExchangeNYSE
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)24,233 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)301.75 USD (100)
Ask (Ask size)430.07 USD (100)
Open340.87 USD
High346.82 USD
Low337.26 USD
Close (prev. day)338.84 USD
VWAP340.121272 USD
Volume (pcs)214,993
Trading volume73,179,509.11
Number of trades8,367
Last size29,438

Futures and Options

Related Futures-
Related Options-
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2022/08/11 22:04:43
Price
337.75 USD
Difference -0.32% (-1.09)

General attributes

ISINUS9553061055
SymbolWST
ExchangeNYSE
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)24,233 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)301.75 USD (100)
Ask (Ask size)430.07 USD (100)
Open340.87 USD
High346.82 USD
Low337.26 USD
Close (prev. day)338.84 USD
VWAP340.121272 USD
Volume (pcs)214,993
Trading volume73,179,509.11
Number of trades8,367
Last size29,438

Performance and Risk

6m1Y3Y
Perf (%)-13.66%-20.12%+134.68%
Perf (abs.)-53.45-85.06+193.83
Beta1.151.080.88
Volatility37.6334.0032.50
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)337.43 USD (248,673)
Ø price 30 days | Ø volume 30 days (pcs.)319.47 USD (405,556)
Ø price 100 days | Ø volume 100 days (pcs.)331.48 USD (425,269)
Ø price 250 days | Ø volume 250 days (pcs.)384.36 USD (405,602)
YTD High | date468.05 USD (2022/01/03)
YTD Low | date275.89 USD (2022/06/14)
52 Weeks High | date475.35 USD (2021/09/09)
52 Weeks Low | date275.89 USD (2022/06/14)

All listings for WEST PHARMACEUTIC.SERVICES INC

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Xetra2022/08/1117:35333.90 EUR0.002
Tradegate2022/08/1122:01327.55 EUR0.001
Stuttgart2022/08/1208:02324.90 EUR0.001
NYSE2022/08/1122:04337.75 USD73.188,367
Munich2022/08/1208:02327.85 EUR0.001
Hanover2022/08/1208:01325.55 EUR0.001
Frankfurt2022/08/1208:40325.55 EUR0.001
Duesseldorf2022/08/1213:01326.85 EUR0.005
Berlin2022/08/1208:10325.40 EUR0.001

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=115621&ID_TYPE_IMAGE_LOGO=2

Contact Details

WEST PHARMACEUTICAL SERVICES INC.
- -
PO Box 645, Gordon Drive 101 19341-0645 Lionville, PA
Telefon: +1 610 594 3319
Fax: +1 610 594 3000
E-mail: Mike.Anderson@westpharma.com

Company Profile

-

Members of Management Board

Myla Lai-GoldmanMember of Board of Directors
Stephen LockhartMember of Board of Directors
William FeeheryMember of Board of Directors
Deborah KellerMember of Board of Directors
Douglas MichelsMember of Board of Directors
Mark ButhmanMember of Board of Directors
Molly JosephMember of Board of Directors
Paolo PucciMember of Board of Directors
Robert FrielMember of Board of Directors
Thomas HofmannMember of Board of Directors
Eric M. GreenChairman of Managing Board
Quintin LaiMember of Executive Committee
Andy PolywaczMember of Executive Committee
Annette F. FavoriteMember of Executive Committee
Bernard J. BirkettMember of Executive Committee
Chris RyanMember of Executive Committee
Cindy Reiss-ClarkMember of Executive Committee
David A. MontecalvoMember of Executive Committee
Kimberly Banks MacKayMember of Executive Committee
Silji AbrahamMember of Executive Committee






Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer